Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Research on the Development and Validation of Personalized Exercise Prescription System for Breast Cancer Patients Based on Large Language ModelsNot Yet Recruiting
NCT07767565N/AUpdated Aug 17, 2026
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer · Exercise and Recovery
China
Inspiratory Muscle Training in Obese Breast Cancer SurvivorsCompleted
NCT05193149NAUpdated Aug 17, 2026
Sponsor: Ohio State University Comprehensive Cancer Center
Cancer Survivors · Obesity · Breast Cancer
United States
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainRecruiting
NCT06500455Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Digestive System Carcinoma · Metastatic Lung Non-Small Cell Carcinoma
United States, Canada, Hong Kong, Ireland
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without ReconstructionRecruiting
NCT07047872NAUpdated Aug 17, 2026
Sponsor: Mayo Clinic
Breast Carcinoma
United States
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruiting
NCT05463796N/AUpdated Aug 17, 2026
Sponsor: Dana-Farber Cancer Institute
Cancer Risk · Cancer Predisposition Syndrome · Hereditary Cancer Prediction · Childhood Cancer Survivors
United States
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast CancerRecruiting
NCT07768436Phase 2Updated Aug 17, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Adenocarcinoma of the Breast · Breast Cancer · Triple Negative Breast Cancer
United States
A Study of HLD-0117 in Patients With Metastatic Breast CancerRecruiting
NCT07524855Phase 1Updated Aug 17, 2026
Sponsor: Janssen Research & Development, LLC
Metastatic Breast Cancer
United States
EXERT-BC Cardio: Cardio or Conditioning Training With Breast CancerRecruiting
NCT07739563NAUpdated Aug 17, 2026
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Cancer · Breast Cancer
United States
Efficacy of Kinesio Taping Versus Compression Therapy on Breast Lymphedema Induced by Radiotherapy After Breast-Conserving SurgeryRecruiting
NCT07767305NAUpdated Aug 17, 2026
Sponsor: Tangshan People's Hospital
Breast Cancer · Breast Lymphedema
China
Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast CancerCompleted
NCT01180335Phase 3Updated Aug 17, 2026
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Breast Cancer
France
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)Recruiting
NCT07541079Phase 3Updated Aug 17, 2026
Sponsor: Genentech, Inc.
Early Breast Cancer
United States
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic MalignanciesEnrolling By Invitation
NCT03762733N/AUpdated Aug 17, 2026
Sponsor: National Cancer Institute (NCI)
Breast Cancer · Ovarian Cancer · Uterine Cancer
United States
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer PatientsTerminated
NCT07173101Phase 2Updated Aug 17, 2026
Sponsor: University of Utah
Breast Cancer · Gynecologic Cancer · Cancer-related Cognitive Difficulties
United States
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruiting
NCT06492616Phase 3Updated Aug 17, 2026
Sponsor: Stemline Therapeutics, Inc.
Breast Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsRecruiting
NCT04895709Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Bristol-Myers Squibb
Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer · Non-Small-Cell Lung Cancer
United States, Australia, Canada, Germany, Israel +3 more
Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsActive Not Recruiting
NCT06635447Phase 3Updated Aug 17, 2026
Sponsor: AstraZeneca
Breast Cancer
China
Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast CancerRecruiting
NCT06869629NAUpdated Aug 17, 2026
Sponsor: Karolinska Institutet
Breast Carcinoma · Breast Cancer · Breast Surgery
Finland, South Korea, Sweden
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialRecruiting
NCT06500481Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Metastatic Malignant Neoplasm in the Leptomeninges
United States
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRIRecruiting
NCT04332588Phase 1Updated Aug 17, 2026
Sponsor: University of Alabama at Birmingham
HER2-positive Breast Cancer
United States
A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsRecruiting
NCT05461768Phase 1Updated Aug 17, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Breast Cancer · Locally Advanced or Metastatic Solid Tumor
China
Risk Communication Within Mexican-American FamiliesCompleted
NCT00469339N/AUpdated Aug 17, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Breast Cancer · Diabetes · Colon Cancer · Cardiovascular Disease
United States
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Active Not Recruiting
NCT04862663Phase 3Updated Aug 17, 2026
Sponsor: AstraZeneca
Locally Advanced (Inoperable) or Metastatic Breast Cancer
United States, Argentina, Australia, Belgium, Brazil +18 more
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast CancerActive Not Recruiting
NCT01266642Phase 2Updated Aug 17, 2026
Sponsor: M.D. Anderson Cancer Center
Ductal Breast Carcinoma In Situ · Invasive Breast Carcinoma · Stage I Breast Cancer AJCC v6 · Stage IA Breast Cancer AJCC v7
United States
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerRecruiting
NCT07085767Phase 3Updated Aug 17, 2026
Sponsor: Olema Pharmaceuticals, Inc.
Breast Cancer · Locally Advanced Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer
United States, Australia, Austria, Belgium, Canada +18 more
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)Active Not Recruiting
NCT04546009Phase 3Updated Aug 17, 2026
Sponsor: Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
United States, Argentina, Australia, Austria, Belgium +25 more

Previous page Next page